Early genomic responses to salicylic acid in Arabidopsis
In these cases, the clinical decision involves weighing ongoing symptoms against therapeutic benefitsimproved glycemic control, weight loss, and potential cardiovascular benefits demonstrated in specific medications
McGuire DK, Marx N, Mulvagh SL, et al
This personalized approach remains valuable even after generics launch, because genetic insights guide dose optimization and compound selection
Shauna Levy, a specialist in obesity medicine and the medical director of the Tulane Bariatric Center in New Orleans, told NBC News the drugs could cause gastroparesis, but the problem could also be caused by another undiagnosed illness or the patients diabetes, and then made worse by the medications